Abivax Cash Flow Statement (2023-2025) | ABVX

Cash Flow Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -46.57M-41.75M-60.65M-42.08M-55.09M-54.80M-179.28M
Share-based Compensation 6.25M6.10M4.77M4.76M4.93M7.17M13.42M
Gains from Investment Securities -0.42M1.95M31.99M1.14M-2.28M35.00M
Cash from Operations -37.76M-54.30M-38.86M-35.81M-35.00M-37.74M-83.33M
Depreciation, Depletion & Amortization
Amortization 80.12M125.19M116.71M151.70M86.50M
Depreciation & Amortization (CF) 0.23M0.39M0.27M0.30M0.29M0.28M0.32M
Change in Working Capital
Change in Receivables -0.74M5.06M-2.27M
Change in Account Payables 5.65M-24.21M15.01M0.18M13.42M1.11M-32.73M
Investing Activities
Change in Net Loans 55.46M
Capital Expenditures -0.01M-0.24M-0.34M1.27M-0.05M-0.02M0.01M
Cash from Investing Activities 2.07M12.45M1.92M0.59M1.14M0.21M3.83M
Financing Activities
Other financing activities 0.00M0.26M0.00M0.26M0.06M
Debt Issuance and Repayment
Short-Term Debt repayments -0.16M-0.14M-0.14M-0.24M-0.26M-0.38M
Change in Capital Stock
Shares Issued 599.51M0.00M
Misc.
Cash from Financing Activities 23.03M20.59M-6.91M-6.23M-8.24M-9.92M705.48M
Exchange Rate Effect 1.43M0.49M-2.13M2.73M-0.74M-1.23M-8.36M
Change in Cash -11.23M-20.77M-45.98M-38.71M-42.75M-48.25M618.14M
Beginning Cash Balance -21.94M
Free Cash Flow -37.74M-54.06M-38.52M-37.08M-34.96M-37.72M-83.34M
Net Cash Flow -12.66M-21.26M-43.85M-41.44M-42.11M-47.45M625.98M